Page last updated: 2024-12-07

11-hydroxytestosterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 11-Hydroxytestosterone: A Crucial Player in Hormone Research

**11-Hydroxytestosterone** (11-OH-T) is a steroid hormone, specifically an **androgen**, that is a metabolite of testosterone. It is produced in the adrenal glands and, to a lesser extent, the testes.

While 11-OH-T has a weaker androgenic activity compared to testosterone, it plays a crucial role in research due to its unique characteristics and potential implications:

**Importance for Research:**

* **Potential role in health and disease:**
* **Cardiovascular health:** Some studies suggest 11-OH-T might be associated with an increased risk of cardiovascular disease. This is because it can potentially interfere with the normal functions of testosterone and its receptors.
* **Metabolic disorders:** Research is ongoing to understand the potential role of 11-OH-T in conditions like obesity and insulin resistance.
* **Brain function:** 11-OH-T has been shown to bind to androgen receptors in the brain, potentially affecting neurotransmitter activity and impacting cognitive function.
* **Prostate cancer:** Further investigation is needed to understand the possible link between elevated 11-OH-T levels and the development of prostate cancer.
* **Potential therapeutic applications:**
* **Treating androgen deficiency:** Some studies suggest that 11-OH-T could potentially be used to treat androgen deficiency in men. This is because it can activate androgen receptors and potentially have fewer side effects than testosterone itself.
* **Developing new medications:** 11-OH-T could potentially serve as a starting point for developing new drugs targeting androgen receptors, potentially leading to novel therapies for various conditions.
* **Understanding hormone metabolism:**
* 11-OH-T provides insights into the complex metabolic pathways involved in testosterone production and degradation. This information can be valuable for understanding hormonal imbalances and developing therapies.
* **Animal research:**
* 11-OH-T is often used in animal research to study the effects of androgens on various physiological processes and disease models.

**Further research on 11-hydroxytestosterone is essential to understand its full potential and implications for human health.**

**Note:** It is important to remember that while 11-OH-T is a fascinating research subject, more research is needed to fully understand its role in human health and its potential therapeutic applications.

11-hydroxytestosterone: RN given refers to (11 beta,17 beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

11beta-hydroxytestosterone : An androstanoid that is testosterone carrying an additional hydroxy substituent at the 11beta-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID114920
CHEMBL ID486718
CHEBI ID81481
SCHEMBL ID619054
MeSH IDM0114421

Synonyms (30)

Synonym
androst-4-en-3-one,17-dihydroxy-, (11.beta.,17.beta.)-
mls002638245 ,
nsc-12168
1816-85-9
nsc12168
androst-4-en-3-one, 11,17-dihydroxy-, (11.beta.,17.beta.)-
11beta-hydroxytestosterone
C18075
11beta,17beta-dihydroxy-4-androsten-3-one
11-hydroxytestosterone
chebi:81481 ,
CHEMBL486718
11beta-hydroxy-testosterone
(8s,9s,10r,11s,13s,14s,17s)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
nsc 12168
11beta,17beta-dihydroxyandrost-4-en-3-one
androst-4-en-3-one, 11,17-dihydroxy-, (11beta,17beta)-
bef7k94mwq ,
unii-bef7k94mwq
SCHEMBL619054
11beta,17beta-dihydroxyandrost-4-ene-3-one
(11beta,17beta)-11,17-dihydroxyandrost-4-en-3-one
11,17-dihydroxyandrost-4-en-3-one #
YQDZGFAYWGWSJK-SLMGBJJTSA-N
4-androsten-11.beta.,17.beta.-diol-3-one
Q27155408
DTXSID70939454
11.beta.-hydroxytestosterone
11-hydroxytestosterone, 11.beta.-
4-androstene-11.beta.,17.beta.-diol-3-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
17beta-hydroxy steroidA 17-hydroxy steroid in which the hydroxy group at position 17 has a beta-configuration.
3-oxo-Delta(4) steroidA 3-oxo steroid conjugated to a C=C double bond at the alpha,beta position.
androstanoidAny steroid based on an androstane skeleton and its derivatives.
C19-steroidA steroid compound with a structure based on a 19-carbon (androstane) skeleton.
11beta-hydroxy steroidAny 11-hydroxy steroid in which the hydroxy group at position 11 has beta- configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID404841Lipophilicity, log P of the compound2008Bioorganic & medicinal chemistry, Jun-15, Volume: 16, Issue:12
Chemometric and chemoinformatic analyses of anabolic and androgenic activities of testosterone and dihydrotestosterone analogues.
AID404840Ratio of anabolic activity in rat levator ani muscle to androgenic activity in rat seminal vesicle2008Bioorganic & medicinal chemistry, Jun-15, Volume: 16, Issue:12
Chemometric and chemoinformatic analyses of anabolic and androgenic activities of testosterone and dihydrotestosterone analogues.
AID624619Specific activity of expressed human recombinant UGT2B72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID404838Androgenic activity in rat assessed as inverse logarithm of amount of enlargement of ventral prostate2008Bioorganic & medicinal chemistry, Jun-15, Volume: 16, Issue:12
Chemometric and chemoinformatic analyses of anabolic and androgenic activities of testosterone and dihydrotestosterone analogues.
AID404839Androgenic activity in rat assessed as inverse logarithm of amount of enlargement of seminal vesicle2008Bioorganic & medicinal chemistry, Jun-15, Volume: 16, Issue:12
Chemometric and chemoinformatic analyses of anabolic and androgenic activities of testosterone and dihydrotestosterone analogues.
AID404837Anabolic activity in rat assessed as inverse logarithm of amount of increase in levator ani muscle weight2008Bioorganic & medicinal chemistry, Jun-15, Volume: 16, Issue:12
Chemometric and chemoinformatic analyses of anabolic and androgenic activities of testosterone and dihydrotestosterone analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (52.17)18.7374
1990's5 (21.74)18.2507
2000's2 (8.70)29.6817
2010's2 (8.70)24.3611
2020's2 (8.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.66 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (8.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (4.35%)0.25%
Other20 (86.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]